D-0292-2021 Class II Terminated
FDA drug recall D-0292-2021 was initiated by Dr. Reddy's Laboratories, Inc. on Feb 26, 2021 and is designated Class II. Reason for recall: Failed Dissolution Specifications: Out-of-specification results observed for dissolution during stability testing. The recall status is terminated (terminated Feb 17, 2022). Affected quantity: 16,449 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 10, 2021
- Initiation Date
- Feb 26, 2021
- Termination Date
- Feb 17, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 16,449 bottles
Product description
Progesterone Capsules, 200 mg, 100-count bottles, Rx Only, MADE IN FRANCE; Distributed by: Dr. Reddy's Laboratories, Inc., Princeton, NJ 08540; NDC 43598-350-01.
Reason for recall
Failed Dissolution Specifications: Out-of-specification results observed for dissolution during stability testing.
Distribution pattern
Nationwide in the USA
Code information
Batch # 1399851P1, Exp 02/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0292-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026